Piezoelectric nanozymes pair enzyme-like catalysis with mechanical energy to generate tumor-killing ROS

Cancer treatment continues to be constrained by the biology of tumors themselves. Conventional therapeutic modalities are frequently limited by tumor hypoxia, heterogeneity, therapeutic resistance and off-target toxicity, according to a review published in the journal Cancer Nanotechnology. Because solid tumors often develop resistance mechanisms and progress rapidly, the authors argue that more robust and precise therapeutic approaches are needed, and they point to an emerging class of materials as a candidate solution: piezoelectric nanozymes.

Nanozymes are nanomaterials that mimic the catalytic activity of natural enzymes, and they have opened new avenues for catalytic cancer therapy. The strategy relies on generating reactive oxygen species, highly reactive molecules that can damage and kill tumor cells from within. Yet traditional nanozyme approaches have run into a persistent obstacle. Their catalytic efficiency is often low, and they produce minimal amounts of reactive oxygen species within the tumor microenvironment, the distinct chemical and physical surroundings of a tumor that can suppress oxidative attack.

Piezoelectric nanozymes are presented in the review as a next-generation category of multifunctional nanocatalysts that integrate enzyme-mimicking catalytic activity with piezoelectric energy conversion. Piezoelectric materials generate electric charge when subjected to mechanical force. By coupling that property to catalysis, these nanocatalysts can be activated by external mechanical stimulation, enabling what the authors describe as effective and accurate tumor treatment without relying solely on the tumor’s own chemistry to drive the reaction.

The central mechanism involves piezoelectric polarization, the charge separation that arises inside a piezoelectric material under mechanical deformation. According to the review, this polarization-mediated enhanced charge separation facilitates catalytic amplification, reactive oxygen species generation, enhanced electron transfer and redox regulation. In practical terms, the mechanical energy delivered to the material is converted into separated electrical charges that then participate in catalytic reactions, amplifying the production of the oxidative species responsible for tumor cell killing while addressing major constraints associated with conventional therapeutic techniques.

The review, authored by Akanksha Deshwal, A. Vimal, Prachi Nirwan and Ravi Mani Tripathi, comprehensively describes the charge-generating properties of piezoelectric materials with enzyme-mimicking catalytic activity, the catalytic mechanisms involved, design strategies and current advancements in piezoelectric nanozyme-driven cancer therapy. It is published open access and was released on 17 August 2026 as a peer-reviewed, citable version that will later be replaced by the final Version of Record.

A substantial portion of the review is devoted to the therapeutic modalities that piezoelectric nanozymes can power. The authors discuss sonodynamic therapy, ferroptosis therapy, radiocatalytic therapy, starvation therapy, piezocatalytic therapy, chemodynamic therapy and immunotherapy, along with their synergistic combinations. Each of these approaches attacks tumors through a different route, from sound-triggered chemistry to iron-dependent cell death to blocking the nutrient supply that tumors need to grow, and the review examines them in detail as applications of the same underlying nanocatalyst platform.

The unifying theme across these modalities is localized reactive oxygen species generation combined with modulation of the tumor microenvironment. Rather than delivering a drug that circulates broadly through the body, the piezoelectric approach concentrates oxidative damage at the tumor site, triggered on demand by external mechanical stimulation. The authors describe this as a versatile platform for multimodal cancer therapy, meaning that a single nanocatalyst could in principle support several treatment modes at once or in sequence.

The significance of the approach lies in how it sidesteps two of the most stubborn barriers in catalytic therapy. Low catalytic efficiency and insufficient reactive oxygen species production have limited earlier nanozyme designs, particularly under the oxygen-poor conditions that characterize many tumors. By supplying energy externally through mechanical stimulation and using piezoelectric polarization to enhance charge separation and electron transfer, piezoelectric nanozymes aim to sustain catalytic output even where the tumor microenvironment would otherwise dampen it, while redox regulation further tunes the chemical balance at the treatment site.

The review positions piezoelectric nanozymes as a promising paradigm for developing strategies for precise, non-invasive cancer therapy. Because the activating stimulus is mechanical and applied from outside the body, the authors frame the platform as compatible with non-invasive treatment concepts, with the nanocatalysts doing their work locally through ROS generation and tumor microenvironment modulation. As research in this area advances, the design strategies and catalytic mechanisms catalogued in this review are intended to serve as a foundation for the next generation of tumor therapeutics built on these dual-function nanomaterials.

Subject of Research: Piezoelectric nanozymes as multifunctional nanocatalysts for catalytic cancer therapy

Article Title: Piezoelectric nanozymes: a new frontier for next-generation tumor therapeutics

Article References: Deshwal, A., Vimal, A., Nirwan, P., & Tripathi, R. M. (2026). Piezoelectric nanozymes: a new frontier for next-generation tumor therapeutics. Cancer Nanotechnology. https://doi.org/10.1186/s12645-026-00414-w

Image Credits: AI Generated

DOI: 10.1186/s12645-026-00414-w

Keywords: piezoelectric nanozymes, catalytic cancer therapy, reactive oxygen species, tumor microenvironment, sonodynamic therapy, ferroptosis, chemodynamic therapy, piezocatalytic therapy, nanomedicine, tumor hypoxia, Piezoelectric, nanozymes